Atlas Trials

PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients

Clinical trial NCT03907826 · RECRUITING

Trial details

NCT number
NCT03907826
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Recurrent Nasopharyngeal Carcinoma
Start date
2020-03-01
Primary completion
2026-12-01
Enrollment
212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.